Reports second quarter revenue of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(1.97)Reiterates plan ...
Moderna beat Wall Street estimates for second-quarter revenue on Friday, helped by vaccine partnership payments and ...
July 31 (Reuters) - Moderna beat Wall Street estimates for second-quarter revenue on Friday, benefiting from its long-term ...
Norovirus vaccine mRNA-1403 missed the Phase 3 interim efficacy bar in Moderna's Q2 2026 earnings disclosure Thursday, ...
The company behind Sharpie markers and Elmer's glue said Friday it now expects full-year normalized earnings per share to be 73 cents to 77 cents, up from 56 cents to 60 cents previously. The energy ...
U.S. futures were higher early Friday as Wall Street staged a sharp rebound, with upbeat earnings from Amazon adding to ...
ExxonMobil's earnings doubled and Chevron posted its highest quarterly earnings on record as energy prices soared during the prolonged closure of the Strait of Hormuz. BP Puts U.K. North Sea Business ...
Pfizer's non-COVID commercial portfolio is accelerating, with new launches and business development products growing 22% to a nearly $12 billion annualized run rate. Seagen's oncology portfolio ...
The company is betting heavily on its cancer pipeline, particularly intismeran autogene, as another infectious disease ...
Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results this Friday before market hours. Here’s what ...
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results this Monday after the bell. Here’s what to look for.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results